RU95115409A -
APPLICATION OF ANTI-VASCULAR MEDICINES IN TREATMENT OF PARKINSON'S DISEASE AND PARKINSON'S SYNDROMES
- Google Patents
APPLICATION OF ANTI-VASCULAR MEDICINES IN TREATMENT OF PARKINSON'S DISEASE AND PARKINSON'S SYNDROMES
Info
Publication number
RU95115409A
RU95115409ARU95115409/14ARU95115409ARU95115409ARU 95115409 ARU95115409 ARU 95115409ARU 95115409/14 ARU95115409/14 ARU 95115409/14ARU 95115409 ARU95115409 ARU 95115409ARU 95115409 ARU95115409 ARU 95115409A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рон-Пуленк Роре С.А.filedCriticalРон-Пуленк Роре С.А.
Publication of RU95115409ApublicationCriticalpatent/RU95115409A/en
1. Применение противосудорожного средства, выбранного среди карбамазепина и окскарбазепина или фармацевтически пригодных солей названных соединений, в качестве лекарственных средств для лечения болезни Паркинсона или синдромов Паркинсона.1. The use of an anticonvulsant selected among carbamazepine and oxcarbazepine or pharmaceutically acceptable salts of these compounds as medicaments for the treatment of Parkinson's disease or Parkinson's syndromes. 2. Применение по п. 1 в качестве лекарственного средства, содержащего от 25 до 200 мг карбамазепина или окскарбазепина. 2. The use according to claim 1 as a medicine containing from 25 to 200 mg of carbamazepine or oxcarbazepine.
RU95115409/14A1993-01-071994-01-03
APPLICATION OF ANTI-VASCULAR MEDICINES IN TREATMENT OF PARKINSON'S DISEASE AND PARKINSON'S SYNDROMES
RU95115409A
(en)
3- and 5-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof, a pharmaceutical preparation containing said compounds and the use of said compounds for the preparation of medicaments.
Process for producing pharmaceutical compositions against endogeneous parasites and a group of the active components, namely the new n-substituted oxy-carbonyl-esters